Aptevo Therapeutics (APVO) Earnings Analysis

Aptevo Therapeutics (APVO) next reports earnings on 2026-08-10, consensus EPS -6.02 USD. Last quarter (2026-03-20) it beat with EPS 1,684.47 USD vs -8.09 USD est (+20921.6%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -0.01.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does APVO next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-6.02 USD
Revenue estimaten/a

APVO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-201,684.47 USD-8.09 USD+20921.6%Beat
2025-08-11-151.08 USD-0.45 USD-33473.3%Miss
2025-05-15-1,579.14 USD-1,514.39 USD-4.3%Miss
2025-03-04-82.37 USD-7.75 USD-962.8%Miss
2024-11-07-6,255.86 USD-7,428.84 USD+15.8%Beat
2024-08-08-21,765.2 USD-25,153.79 USD+13.5%Beat

Beat rate: 3/6 (50%) over reported quarters with consensus data.

APVO valuation and analyst view

Trailing P/E-0.01
Trailing EPS-24.75398 USD
Price / book0.41
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Aptevo Therapeutics (APVO)'s next earnings date?

Aptevo Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -6.02 USD.

Did APVO beat earnings last quarter?

In its 2026-03-20 report, APVO posted EPS of 1684.47 USD versus a -8.09 USD estimate — a beat of 20921.6%.

What is APVO's earnings track record?

Over the last 6 reported quarters with consensus data, APVO beat estimates 3 times (50%).

What is APVO's current P/E ratio and EPS?

APVO trades at a trailing P/E of -0.01 on trailing EPS of -24.75397811588437 USD.

What do analysts rate APVO?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).